Browse by Changes
Summary of Changes – 1 February 2015
Previous versions of the Summary of Changes are available in PDF in the Publications Archive.
- Additions
- Deletions
- Advance Notices
- Prescriber Bag
- Palliative Care
- Highly Specialised Drugs Program (Public Hospital)
- Highly Specialised Drugs Program (Private Hospital)
- Efficient Funding of Chemotherapy (Public Hospital)
- Efficient Funding of Chemotherapy (Private Hospital)
- Repatriation Schedule of Pharmaceutical Benefits (RPBS)
Addition – Item
| 10211K | MIFEPRISTONE (&) MISOPROSTOL, mifepristone 200 mg tablet [1] (&) misoprostol 200 microgram tablet [4], 1 pack (MS-2 Step) |
| 10210J | PNEUMOCOCCAL PURIFIED CAPSULAR POLYSACCHARIDES, pneumococcal purified capsular polysaccharides 25 microgram/0.5 mL injection, 1 x 0.5 mL syringe (Pneumovax 23) |
Addition – Brand
| 8179L | Anastrozole FBM, FO – ANASTROZOLE, anastrozole 1 mg tablet, 30 |
| 2729P | Chem mart Baclofen, CH – BACLOFEN, baclofen 10 mg tablet, 100 |
| 2729P | GenRx Baclofen, GX – BACLOFEN, baclofen 10 mg tablet, 100 |
| 2729P | Terry White Chemists Baclofen, TW – BACLOFEN, baclofen 10 mg tablet, 100 |
| 2730Q | Chem mart Baclofen, CH – BACLOFEN, baclofen 25 mg tablet, 100 |
| 2730Q | GenRx Baclofen, GX – BACLOFEN, baclofen 25 mg tablet, 100 |
| 9296G | Clopidogrel/Aspirin Actavis 75/100, GN – CLOPIDOGREL + ASPIRIN, clopidogrel 75 mg + aspirin 100 mg tablet, 30 |
| 8532C | Odaplix SR, AF – INDAPAMIDE, indapamide hemihydrate 1.5 mg tablet: modified release, 90 tablets |
| 8247C | Irbesartan Actavis 150, UA – IRBESARTAN, irbesartan 150 mg tablet, 30 |
| 8405J | Irbesartan HCT Actavis 300/12.5, UA – IRBESARTAN + HYDROCHLOROTHIAZIDE, irbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
| 3064G | Dulose, FM – LACTULOSE, LACTULOSE Mixture 3.34 g per 5 mL, 500 mL, 1 |
| 9331D | Lansoprazole ODT GH, GQ – LANSOPRAZOLE, lansoprazole 15 mg tablet: orally disintegrating, 28 tablets |
| 9477T | Lansoprazole ODT GH, GQ – LANSOPRAZOLE, lansoprazole 30 mg tablet: orally disintegrating, 28 tablets |
| 8245Y | Letrozole FBM, FO – LETROZOLE, letrozole 2.5 mg tablet, 30 |
| 1818Q | Methotrexate MYX, YN – METHOTREXATE, METHOTREXATE Injection 50 mg in 2 mL, 1 |
| 1324Q | APO-Metoprolol, TX – METOPROLOL TARTRATE, METOPROLOL TARTRATE Tablet 50 mg, 100 |
| 1325R | APO-Metoprolol, TX – METOPROLOL TARTRATE, METOPROLOL TARTRATE Tablet 100 mg, 60 |
Deletion – Item
| 2095G | TICLOPIDINE, ticlopidine hydrochloride 250 mg tablet, 60 (Tilodene) |
Deletion – Brand
| 2360F | Chloromycetin, PF – CHLORAMPHENICOL, chloramphenicol 0.5% eye drops, 10 mL |
| 5055C | Chloromycetin, PF – CHLORAMPHENICOL, chloramphenicol 0.5% eye drops, 10 mL (Dental) |
| 5512D | Chloromycetin, PF – CHLORAMPHENICOL, chloramphenicol 0.5% eye drops, 10 mL (Optometrical) |
| 2592K | GenRx Isotretinoin, GX – ISOTRETINOIN, isotretinoin 20 mg capsule, 60 |
| 2321E | Medroxyprogesterone Sandoz, SZ – MEDROXYPROGESTERONE, medroxyprogesterone acetate 10 mg tablet, 30 |
| 8887R | Meloxicam Sandoz, SZ – MELOXICAM, meloxicam 7.5 mg capsule, 30 |
| 8888T | Meloxicam Sandoz, SZ – MELOXICAM, meloxicam 15 mg capsule, 30 |
| 2430X | GenRx Metformin, GX – METFORMIN, metformin hydrochloride 500 mg tablet, 100 |
| 1801T | GenRx Metformin, GX – METFORMIN, metformin hydrochloride 850 mg tablet, 60 |
| 8456C | Sequase, PM – QUETIAPINE, quetiapine 25 mg tablet, 60 |
| 8457D | Sequase, PM – QUETIAPINE, quetiapine 100 mg tablet, 90 |
| 8458E | Sequase, PM – QUETIAPINE, quetiapine 200 mg tablet, 60 |
| 8580N | Sequase, PM – QUETIAPINE, quetiapine 300 mg tablet, 60 |
Advance Notices
1 March 2015
Deletion – Item
| 8849R | ESCITALOPRAM, escitalopram 10 mg/mL oral liquid, 28 mL |
Deletion – Brand
| 5006L | AMOXYCILLIN + CLAVULANIC ACID, amoxycillin 875 mg + clavulanic acid 125 mg tablet, 10 (GenRx Amoxycillin and Clavulanic Acid) |
| 8254K | AMOXYCILLIN + CLAVULANIC ACID, amoxycillin 875 mg + clavulanic acid 125 mg tablet, 10 (GenRx Amoxycillin and Clavulanic Acid) |
| 2964B | CEPHALOTHIN, cephalothin 1 g injection, 10 x 1 g vials, (Cefalotin Sandoz) |
| 3376Q | CEPHALOTHIN, cephalothin 1 g injection, 10 x 1 g vials, (Cefalotin Sandoz) |
| 1245M | LEVODOPA + CARBIDOPA ANHYDROUS, levodopa 250 mg + carbidopa anhydrous 25 mg tablet, 100, (Levo/Carbidopa Sandoz) |
| 2681D | POLYVINYL ALCOHOL, polyvinyl alcohol 3% eye drops, 15 mL, (PVA Forte) |
| 5525T | POLYVINYL ALCOHOL, polyvinyl alcohol 3% eye drops, 15 mL, (PVA Forte) |
| 9222J | POLYVINYL ALCOHOL, polyvinyl alcohol 3% eye drops, 15 mL, (PVA Forte) |
1 April 2015
Deletion – Item
| 2710P | MIFEPRISTONE, mifepristone 200 mg tablet, 1 |
| 2672P | MISOPROSTOL, misoprostol 200 microgram tablet, 4 |
1 May 2015
Deletion – Item
| 2995P | SALCATONIN, salcatonin 50 international units/mL injection, 5 x 1 mL ampoules |
|
TESTOSTERONE UNDECANOATE, testosterone undecanoate 1 g/4 mL injection, 1 x 4 mL ampoule |
Addition – Item
| 10209H | LIGNOCAINE, lignocaine hydrochloride anhydrous 1% (50 mg/5 mL) injection, 5 x 5 mL ampoules (Pfizer Australia Pty Ltd) |
Addition – Brand
| 5387M | Dulose, FM – LACTULOSE, LACTULOSE Mixture 3.34 g per 5 mL, 500 mL, 1 |
| 5388N | Dulose, FM – LACTULOSE, LACTULOSE Mixture 3.34 g per 5 mL, 500 mL, 1 |
Deletion – Item
| 5333Q | CARMELLOSE SODIUM, carmellose sodium 10 mg/mL oral spray, 25 mL (Aquae) |
| 5335T | CARMELLOSE SODIUM, carmellose sodium 10 mg/mL oral spray, 25 mL (Aquae) |
| 5334R | CARMELLOSE SODIUM, carmellose sodium 10 mg/mL oral spray, 100 mL (Aquae) |
| 5336W | CARMELLOSE SODIUM, carmellose sodium 10 mg/mL oral spray, 100 mL (Aquae) |
| 5421H | HYPROMELLOSE, HYPROMELLOSE Oral gel 20 mg per g, 100 g, 1 (Aquae Gel) |
| 5422J | HYPROMELLOSE, HYPROMELLOSE Oral gel 20 mg per g, 100 g, 1 (Aquae Gel) |
Highly Specialised Drugs Program (Public Hospital)
Deletion – Item
| 5620T | CIDOFOVIR, cidofovir 375 mg/5 mL injection, 1 x 5 mL vial (Vistide) |
Deletion – Item
| 6247T | CIDOFOVIR, cidofovir 375 mg/5 mL injection, 1 x 5 mL vial (Vistide) |
Efficient Funding of Chemotherapy (Public Hospital)
Addition – Brand
| 4451G | Irinotecan MYX, YN – IRINOTECAN, irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 1 x 5 mL vial |
| 4502Y | Methotrexate MYX, YN – METHOTREXATE, METHOTREXATE Injection 50 mg in 2 mL, 1 |
| 4512L | Methotrexate MYX, YN – METHOTREXATE, METHOTREXATE Injection 50 mg in 2 mL, 1 |
| 4502Y | Methotrexate MYX, YN – METHOTREXATE, methotrexate 1 g/10 mL injection, 1 x 10 mL vial |
| 4512L | Methotrexate MYX, YN – METHOTREXATE, methotrexate 1 g/10 mL injection, 1 x 10 mL vial |
| 4542C | Oxaliplatin MYX, YN – OXALIPLATIN, oxaliplatin 100 mg/20 mL injection, 1 x 20 mL vial |
Changes to Restrictions
The following items have additions, deletions or alterations to restrictions and/or notes.
| 4371C | ARSENIC, arsenic trioxide 10 mg/10 mL injection, 10 x 10 mL vials (Phenasen) |
| 4312Y | CETUXIMAB, cetuximab 100 mg/20 mL injection, 1 x 20 mL vial (Erbitux); cetuximab 500 mg/100 mL injection, 1 x 100 mL vial (Erbitux) |
| 4435K | CETUXIMAB, cetuximab 100 mg/20 mL injection, 1 x 20 mL vial (Erbitux); cetuximab 500 mg/100 mL injection, 1 x 100 mL vial (Erbitux) |
| 4364Q | DOXORUBICIN HYDROCHLORIDE-PEGYLATED LIPOSOMAL, doxorubicin hydrochloride-pegylated liposomal 50 mg/25 mL injection, 1 x 25 mL vial (Caelyx); doxorubicin hydrochloride-pegylated liposomal 20 mg/10 mL injection, 1 x 10 mL vial (Caelyx); doxorubicin hydrochloride-pegylated liposomal 20 mg/10 mL injection, 1 x 10 mL vial (Liposomal Doxorubicin SUN); doxorubicin hydrochloride-pegylated liposomal 50 mg/25 mL injection, 1 x 25 mL vial (Liposomal Doxorubicin SUN) |
| 4600D | PEMETREXED, pemetrexed 500 mg injection, 1 x 500 mg vial (Alimta); pemetrexed 100 mg injection, 1 x 100 mg vial (Alimta) |
Efficient Funding of Chemotherapy (Private Hospital)
Addition – Brand
| 7249M | Irinotecan MYX, YN – IRINOTECAN, irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 1 x 5 mL vial |
| 7250N | Methotrexate MYX, YN – METHOTREXATE, METHOTREXATE Injection 50 mg in 2 mL, 1 |
| 7251P | Methotrexate MYX, YN – METHOTREXATE, METHOTREXATE Injection 50 mg in 2 mL, 1 |
| 7250N | Methotrexate MYX, YN – METHOTREXATE, methotrexate 1 g/10 mL injection, 1 x 10 mL vial |
| 7251P | Methotrexate MYX, YN – METHOTREXATE, methotrexate 1 g/10 mL injection, 1 x 10 mL vial |
| 7253R | Oxaliplatin MYX, YN – OXALIPLATIN, oxaliplatin 100 mg/20 mL injection, 1 x 20 mL vial |
Changes to Restrictions
The following items have additions, deletions or alterations to restrictions and/or notes.
| 7241D | ARSENIC, arsenic trioxide 10 mg/10 mL injection, 10 x 10 mL vials (Phenasen) |
| 10114H | BEVACIZUMAB, bevacizumab 100 mg/4 mL injection, 1 x 4 mL vial (Avastin); bevacizumab 400 mg/16 mL injection, 1 x 16 mL vial (Avastin) |
| 10120P | BEVACIZUMAB, bevacizumab 100 mg/4 mL injection, 1 x 4 mL vial (Avastin); bevacizumab 400 mg/16 mL injection, 1 x 16 mL vial (Avastin) |
| 7243F | BEVACIZUMAB, bevacizumab 100 mg/4 mL injection, 1 x 4 mL vial (Avastin); bevacizumab 400 mg/16 mL injection, 1 x 16 mL vial (Avastin) |
| 7236W | CABAZITAXEL, CABAZITAXEL Jevtana Concentrated injection 60 mg (as acetone solvate) in 1.5 mL, with diluent, 1 (Jevtana) |
| 7223E | CETUXIMAB, cetuximab 100 mg/20 mL injection, 1 x 20 mL vial (Erbitux); cetuximab 500 mg/100 mL injection, 1 x 100 mL vial (Erbitux) |
| 7240C | CETUXIMAB, cetuximab 100 mg/20 mL injection, 1 x 20 mL vial (Erbitux); cetuximab 500 mg/100 mL injection, 1 x 100 mL vial (Erbitux) |
| 7242E | CETUXIMAB, cetuximab 100 mg/20 mL injection, 1 x 20 mL vial (Erbitux); cetuximab 500 mg/100 mL injection, 1 x 100 mL vial (Erbitux) |
| 7273T | CETUXIMAB, cetuximab 100 mg/20 mL injection, 1 x 20 mL vial (Erbitux); cetuximab 500 mg/100 mL injection, 1 x 100 mL vial (Erbitux) |
| 7230M | DOXORUBICIN HYDROCHLORIDE-PEGYLATED LIPOSOMAL, doxorubicin hydrochloride-pegylated liposomal 50 mg/25 mL injection, 1 x 25 mL vial (Caelyx); doxorubicin hydrochloride-pegylated liposomal 20 mg/10 mL injection, 1 x 10 mL vial (Caelyx); doxorubicin hydrochloride-pegylated liposomal 20 mg/10 mL injection, 1 x 10 mL vial (Liposomal Doxorubicin SUN); doxorubicin hydrochloride-pegylated liposomal 50 mg/25 mL injection, 1 x 25 mL vial (Liposomal Doxorubicin SUN) |
| 2638W | IPILIMUMAB, ipilimumab 50 mg/10 mL injection, 1 x 10 mL vial (Yervoy); ipilimumab 200 mg/40 mL injection, 1 x 40 mL vial (Yervoy) |
| 2643D | IPILIMUMAB, ipilimumab 50 mg/10 mL injection, 1 x 10 mL vial (Yervoy); ipilimumab 200 mg/40 mL injection, 1 x 40 mL vial (Yervoy) |
| 10069Y | PANITUMUMAB, panitumumab 400 mg/20 mL injection, 1 x 20 mL vial (Vectibix); panitumumab 100 mg/5 mL injection, 1 x 5 mL vial (Vectibix) |
| 7255W | PEMETREXED, pemetrexed 500 mg injection, 1 x 500 mg vial (Alimta); pemetrexed 100 mg injection, 1 x 100 mg vial (Alimta) |
| 10193L | RITUXIMAB, rituximab 100 mg/10 mL injection, 2 x 10 mL vials (Mabthera); rituximab 500 mg/50 mL injection, 1 x 50 mL vial (Mabthera) |
| 7257Y | RITUXIMAB, rituximab 100 mg/10 mL injection, 2 x 10 mL vials (Mabthera); rituximab 500 mg/50 mL injection, 1 x 50 mL vial (Mabthera) |
| 7258B | RITUXIMAB, rituximab 100 mg/10 mL injection, 2 x 10 mL vials (Mabthera); rituximab 500 mg/50 mL injection, 1 x 50 mL vial (Mabthera) |
| 7259C | RITUXIMAB, rituximab 100 mg/10 mL injection, 2 x 10 mL vials (Mabthera); rituximab 500 mg/50 mL injection, 1 x 50 mL vial (Mabthera) |
Alteration – Restriction Level
| From | To | ||
| 7241D | ARSENIC, arsenic trioxide 10 mg/10 mL injection, 10 x 10 mL vials (Phenasen) |
authority-required | streamlined |
| 10114H | BEVACIZUMAB, bevacizumab 100 mg/4 mL injection, 1 x 4 mL vial (Avastin); bevacizumab 400 mg/16 mL injection, 1 x 16 mL vial (Avastin) |
authority-required | streamlined |
| 10120P | BEVACIZUMAB, bevacizumab 100 mg/4 mL injection, 1 x 4 mL vial (Avastin); bevacizumab 400 mg/16 mL injection, 1 x 16 mL vial (Avastin) |
authority-required | streamlined |
| 7243F | BEVACIZUMAB, bevacizumab 100 mg/4 mL injection, 1 x 4 mL vial (Avastin); bevacizumab 400 mg/16 mL injection, 1 x 16 mL vial (Avastin) |
authority-required | streamlined |
| 7236W | CABAZITAXEL, CABAZITAXEL Jevtana Concentrated injection 60 mg (as acetone solvate) in 1.5 mL, with diluent, 1 (Jevtana) |
authority-required | streamlined |
| 7223E | CETUXIMAB, cetuximab 100 mg/20 mL injection, 1 x 20 mL vial (Erbitux); cetuximab 500 mg/100 mL injection, 1 x 100 mL vial (Erbitux) |
authority-required | streamlined |
| 7240C | CETUXIMAB, cetuximab 100 mg/20 mL injection, 1 x 20 mL vial (Erbitux); cetuximab 500 mg/100 mL injection, 1 x 100 mL vial (Erbitux) |
authority-required | streamlined |
| 7242E | CETUXIMAB, cetuximab 100 mg/20 mL injection, 1 x 20 mL vial (Erbitux); cetuximab 500 mg/100 mL injection, 1 x 100 mL vial (Erbitux) |
authority-required | streamlined |
| 7273T | CETUXIMAB, cetuximab 100 mg/20 mL injection, 1 x 20 mL vial (Erbitux); cetuximab 500 mg/100 mL injection, 1 x 100 mL vial (Erbitux) |
authority-required | streamlined |
| 7230M | DOXORUBICIN HYDROCHLORIDE-PEGYLATED LIPOSOMAL, doxorubicin hydrochloride-pegylated liposomal 50 mg/25 mL injection, 1 x 25 mL vial (Caelyx); doxorubicin hydrochloride-pegylated liposomal 20 mg/10 mL injection, 1 x 10 mL vial (Caelyx); doxorubicin hydrochloride-pegylated liposomal 20 mg/10 mL injection, 1 x 10 mL vial (Liposomal Doxorubicin SUN); doxorubicin hydrochloride-pegylated liposomal 50 mg/25 mL injection, 1 x 25 mL vial (Liposomal Doxorubicin SUN) |
authority-required | streamlined |
| 2638W | IPILIMUMAB, ipilimumab 50 mg/10 mL injection, 1 x 10 mL vial (Yervoy); ipilimumab 200 mg/40 mL injection, 1 x 40 mL vial (Yervoy) |
authority-required | streamlined |
| 2643D | IPILIMUMAB, ipilimumab 50 mg/10 mL injection, 1 x 10 mL vial (Yervoy); ipilimumab 200 mg/40 mL injection, 1 x 40 mL vial (Yervoy) |
authority-required | streamlined |
| 10069Y | PANITUMUMAB, panitumumab 400 mg/20 mL injection, 1 x 20 mL vial (Vectibix); panitumumab 100 mg/5 mL injection, 1 x 5 mL vial (Vectibix) |
authority-required | streamlined |
| 7255W | PEMETREXED, pemetrexed 500 mg injection, 1 x 500 mg vial (Alimta); pemetrexed 100 mg injection, 1 x 100 mg vial (Alimta) |
authority-required | streamlined |
| 10193L | RITUXIMAB, rituximab 100 mg/10 mL injection, 2 x 10 mL vials (Mabthera); rituximab 500 mg/50 mL injection, 1 x 50 mL vial (Mabthera) |
authority-required | streamlined |
| 7257Y | RITUXIMAB, rituximab 100 mg/10 mL injection, 2 x 10 mL vials (Mabthera); rituximab 500 mg/50 mL injection, 1 x 50 mL vial (Mabthera) |
authority-required | streamlined |
| 7258B | RITUXIMAB, rituximab 100 mg/10 mL injection, 2 x 10 mL vials (Mabthera); rituximab 500 mg/50 mL injection, 1 x 50 mL vial (Mabthera) |
authority-required | streamlined |
| 7259C | RITUXIMAB, rituximab 100 mg/10 mL injection, 2 x 10 mL vials (Mabthera); rituximab 500 mg/50 mL injection, 1 x 50 mL vial (Mabthera) |
authority-required | streamlined |
Addition – Brand
| 4307Q | Sunsense Sensitive SPF 50+, EO – SUNSCREENS, SUNSCREENS Cream 75 g, 1 |
| 4546G | Sunsense Ultra SPF 50+, EO – SUNSCREENS, SUNSCREENS Lotion (non-alcoholic) 125 mL, 1 |
Deletion – Item
| 4568K | CARMELLOSE SODIUM, carmellose sodium 10 mg/mL oral spray, 25 mL (Aquae) |
| 4569L | CARMELLOSE SODIUM, carmellose sodium 10 mg/mL oral spray, 100 mL (Aquae) |
Deletion – Brand
| 4307Q | Sunsense Sensitive SPF 30+, EO – SUNSCREENS, SUNSCREENS Cream 75 g, 1 |
| 4546G | Hamilton Sunscreen Family Sunscreen Milk SPF 15, KY – SUNSCREENS, SUNSCREENS Lotion (non-alcoholic) 125 mL, 1 |
| 4546G | SunSense Ultra SPF 30+, EO – SUNSCREENS, SUNSCREENS Lotion (non-alcoholic) 125 mL, 1 |
Alteration – Manufacturer Code
| From | To | ||
| 4328T | Colofac – MEBEVERINE, mebeverine hydrochloride 135 mg tablet, 90 | AB | GO |
| 4396J | Hytrin – TERAZOSIN, terazosin 1 mg tablet [7 tablets] (&) terazosin 2 mg tablet [7 tablets], 14 | AB | GO |
| 4397K | Hytrin – TERAZOSIN, terazosin 2 mg tablet, 28 | AB | GO |
| 4398L | Hytrin – TERAZOSIN, terazosin 5 mg tablet, 28 | AB | GO |
| 4399M | Hytrin – TERAZOSIN, terazosin 10 mg tablet, 28 | AB | GO |
